A clinical trial of an experimental cell therapy shows promising results for glioblastoma patients, with tumors disappearing ...

The FDA has approved a new drug called Modeyso for the treatment of diffuse midline glioma (DMG), a rare and aggressive brain ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Glioblastoma is a highly aggressive brain tumor with about a 10% 5-year survival rate. The debilitating disease affects roughly 3 people per 100,000. According to the Mayo Clinic Comprehensive Cancer ...

Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK. But survival for other types, such as stomach, lung and brain cancer, ...

A study has found major variations in survival rates between different cancers, with Cancer Research UK saying some patients ...

Glioblastoma is one of the most aggressive and difficult to treat brain tumors, with low survival rates and limited treatment ...

Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow ...